Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study (TRH)
Hypertension

About this trial
This is an interventional treatment trial for Hypertension focused on measuring Hypertension
Eligibility Criteria
Inclusion Criteria:
- Clinical diagnosis of Treatment Resistant Hypertension (TRH)
- On three or more hypertensive medications at therapeutic dose
- BpTRU measurement on two occasions of >135/85 without diabetes or chronic kidney disease or BP >125/75 if diabetes and/or chronic kidney disease.
- Mean of >10 BP readings of >135/85 mm mercury for those with no diabetes or chronic kidney disease
- Mean of >10 home BP readings of >125/75 mm mercury for those with diabetes and/or chronic kidney disease.
Exclusion Criteria:
- Less than 18 years of age
- Refuses or incompetent to provide consent
- BP controlled to goal in or outside the clinic
- Symptomatic or significant orthostatic hypotension (<20/10 on standing)
- Life-threatening or severe illness
- Currently on protocol
- Myocardial Infarction or stroke in the past 6 months
- Estimated Glomerular Filtration Rate <50 ml/1.7/min.
Sites / Locations
- AnMed
- Beaufort Jasper Hampton Comprehensive Health
- McLeod Family Medicine Center
- Family Diagnostics
- Lovelace Family Medicine
- Carolina Medical Affiliates
- Spartanburg Regional Health Services
- Palmetto Primary Care
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Active Comparator
Active Comparator
Active Comparator
Aldosterone Antagonist
Referral Hypertension specialist
Renin treatment-guided therapeutics
Renin-guided therapeutics and referral
Prescribe an aldosterone antagonist such as Spironolactone 12.5-25 mg daily as a starting dose with a maximum recommended dose of 50 mg daily.
Referral to a hypertension specialist
Renin treatment-guided therapeutics. A treatment algorithm is provided to guide treatment based upon renin levels.
Renin treatment-guided therapeutics and referral to hypertension specialist. Treatment based upon algorithm for treatment related to renin level in addition to referral to a hypertension specialist.